Yarema Kristin

Yarema Kristin is listed in filings as President and CEO at Poseida Therapeutics, Inc.. This profile follows SEC Form 4 activity through Mar 18, 2026, including 7 public disclosures. Recent filings connect the profile to Poseida Therapeutics, Inc. (PSTX) and ImageneBio Inc (IMA). The current snapshot covers public activity from Jan 8, 2025 to Mar 18, 2026. Reported amounts are shown as $5.5M to $1.2M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.